Open AccessComparative efficacy and safety of escitalopram versus desvenlafaxine in postmenopausal women with depression and anxiety: A randomized, open-label, comparative trial
Author(s) -
Sonia Mahajan,
Vishal R Tandon,
Meenakshi Arora,
Annil Mahajan,
Suman Kumar Kotwal
Publication year - 2019
Publication title -
journal of mid-life health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.423
H-Index - 11
eISSN - 0976-7819
pISSN - 0976-7800
DOI - 10.4103/jmh.jmh_139_18
Subject(s) - escitalopram , tolerability , hamilton anxiety rating scale , anxiety , medicine , depression (economics) , randomized controlled trial , adverse effect , psychology , psychiatry , antidepressant , macroeconomics , economics
The aim was to evaluate the comparative efficacy and safety of escitalopram versus desvenlafaxine in postmenopausal women with depression and anxiety in our study cohort.